Brief: aap Implantate Q3 EBITDA loss widens to 1.8 mln euros in continued operation

aap Implantate AG

14/11/2016 22:50

Nov 15 (Reuters) - aap Implantate AG  AAQG.DE : 
    * Said on Monday Q3/2016 sales and EBITDA within the guidance; North America sales in 9 
months of 2016 above expectations; important progress in LOQTEQ portfolio expansion 
    * In the continued operation sales in Q3/2016 amounted to 2.9 million euros ($3.13 
million)(Q3/2015: 3.4 million euros) 
    * Q3 EBITDA of -1.8 million euros (Q3/2015: -1.4 million euros) in the continued operation 
in the third quarter of 2016 
    * Outlook for 2016 in the fourth quarter of 2016, aap aims to achieve further progress in 
its strategy implementation 
    * Based on the business performance to date and taking into account the one-time effects as 
well as the ongoing negotiations, the Management Board expects sales and EBITDA to be at the 
lower end of the guidance for financial year 2016 
 
Source text for Eikon:  ID:nGNEc1483V  
Further company coverage:  AAQG.DE  
 
($1 = 0.9262 euros) 
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))